Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Aug. 15, 2025. Document 2025-15566. Updated Nov. 20, 2026.
- What it does
The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Drug Enforcement Administration has published 27 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This temporary order is effective August 15, 2025, until August 15, 2027. If this order is extended or made permanent, DEA will publish a document in the Federal Register.
The agency's dates, word for word.
The record as published
| Document number | 2025-15566 |
|---|---|
| Action | Temporary amendment; temporary scheduling order. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | Aug. 15, 2025 |
| Effective date | Aug. 15, 2025 |
| Docket | DEA-2024-0118 |
Source: the Federal Register (public domain). The document in the Federal Register